Change in Splenic Volume as a Surrogate Marker for Immunotherapy Response in Patients with Advanced Urothelial and Renal Cell Carcinoma—Evaluation of a Novel Approach of Fully Automated Artificial Intelligence Based Splenic Segmentation.
- Resource Type
- Article
- Source
- Biomedicines; Sep2023, Vol. 11 Issue 9, p2482, 12p
- Subject
RENAL cell carcinoma TRANSITIONAL cell carcinoma BIOMARKERS ARTIFICIAL intelligence PROGNOSIS - Language
- ISSN
- 22279059